Clinical Intelligence/Clinical Efficiency

Medical Intelligence Platform Dr.Evidence Expands Sr. Leadership

Medical Intelligence

Unveils New Identity Emblematic of Purpose: Accelerated Impact™

Dr.Evidence™, the leading medical intelligence platform for life sciences companies, today announced a slate of key commercial and technology hires in senior leadership roles. The company is driven to meet new demands for intelligent technology solutions and expertise that empowers clients and partners to generate breakthrough insights faster, more cost efficiently and, ultimately, develop effective products to meet the needs of patients and physicians worldwide.

“The volume and complexity of medical information is growing at an exponential pace. Technology needs to evolve faster than ever to turn that data into intelligence and actionable insights,” said Chief Executive Officer, Bob Battista. “We’re thrilled to welcome these leaders to the Dr.Evidence team that expand our expertise and deepen partnerships with our clients to unlock new possibilities in scientific discovery.”

The new hires include:

David Dornstreich, Chief Commercial Officer: Bringing more than 20 years of life science experience, David will lead the Business Development, Client Success, and Marketing teams. Most recently, David was Vice President, Strategic Initiatives and Data Partnerships at Veradigm, an Allscripts company, where he was responsible for data solutions for biopharma business development. Previously, he led growth plans and strategic partnerships for nonprofit medical societies, including ASCO’s CancerLinQ and the American College of Cardiology. David will serve as a member on the company’s executive committee.

Umut Eser, PhD, Chief Innovation Officer: Umut will be responsible for enhancing Dr.Evidence artificial intelligence/machine learning solutions. Umut earned his PhD in Applied Physics from Stanford University and was a Postdoctoral Research Scientist in Genetics at Harvard University. Prior to joining Dr.Evidence, Umut was Head of Machine Learning Research at Cellarity.

Arturo Devesa, Head of Search Technology: Arturo joins the team to lead DocSearch™, managing the software engineering team. Arturo’s expertise stems from his time as a research scholar at Stanford University Medical School studying machine learning, as well as his experience as an instructor in Statistics and Information Technology at Florida Atlantic University. Arturo earned his MS in Mathematical Economics – Econometrics and Applied Statistics at Florida Atlantic University. Prior to joining Dr.Evidence, Arturo served as Founder & CEO of MedWhat, an intelligent personal medical and health assistant.

“At Dr.Evidence we are committed to continually investing in talent and technology,” stated Joseph A. Boystak, Chairman of the Board. “We are confident this combination, in collaboration with our clients and partners, will result in remarkable achievements.”

To further demonstrate the company’s commitment to unlocking possibilities in science, Dr.Evidence recently rebranded with a new visual identity and articulation of the organization’s promise: Accelerated Impact™. The new logo, with its “dot,” is designed to represent the point of clarity that Dr.Evidence brings to bear in a growing sea of evidence.

For more such updates and perspectives around Digital Innovation, IoT, Data Infrastructure, AI & Cybsercurity, go to

Related posts

Study Ranks Rush No. 2 Among 101 Medical Academic Medical Centers

PR Newswire

Optellum Receives FDA Clearance for AI Clinical Decision Software

Business Wire

Ajax Therapeutics Raises $40 Million

Business Wire